SAB Biotherapeutics, Inc.: Form 8-K, filed Apr 22, 2026
Filed with the SEC on Apr 22, 2026 and accepted by EDGAR at Apr 22, 2026, 12:13 ET.
Items reported
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-168569. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.